CRT And Bayer Schering Pharma To Investigate New Therapeutic Approach In Gynaecological And Oncological Diseases

Research Technology has signed an agreement with Bayer Schering Pharma AG, Germany to evaluate new leptin antagonist peptides as potential experimental treatments initially in the area of gynaecological diseases, including


Read more

Related posts

Leave a Reply